Iveric Bio Inc (ISEE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ISEE | CRSP | ACAD | ||
| Company | Iveric Bio Inc | Crispr Therapeutics Ag | Acadia Pharmaceutica | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 39.86 | 57.93 | 30.14 | ||
| High | 39.99 | 61.55 | 30.76 | ||
| Low | 39.85 | 57.51 | 29.84 | ||
| Last | 39.95 | 60.90 | 30.57 | ||
| Change | +0.15 | +3.83 | +0.92 | ||
| Percent Change | +0.38% | +6.70% | +3.10% | ||
| Volume | 10,999,100 | 2,083,600 | 1,523,700 | ||
| 20-Day Average Volume | 5,716,510 | 1,559,210 | 1,834,875 | ||
| Previous | 39.80 | 57.08 | 29.65 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 39.01 | 53.80 | 28.55 | ||
| 20-Day Raw Stochastic | 98.96% | 89.60% | 93.05% | ||
| 20-Day Relative Strength | 69.12 | 62.48 | 67.06 | ||
| Weighted Alpha | +139.70 | +20.31 | +32.66 | ||
| Today's Opinion | 100% Buy | 88% Buy | 88% Buy | ||
| Yesterday's Opinion | 100% Buy | 72% Buy | 88% Buy | ||
| Last Month's Opinion | 100% Buy | 56% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.55% since 06/30/23 | +14.97% since 08/18/26 | +1.29% since 08/18/26 | ||
| Low | 39.34 on 07/03/23 | 54.99 on 08/19/26 | 28.80 on 08/21/26 | ||
| High | 39.99 on 07/10/23 | 62.53 on 08/21/26 | 30.96 on 08/19/26 | ||
| 1-Month | |||||
| %Chg | +4.80% since 06/09/23 | +30.86% since 07/24/26 | +23.07% since 07/24/26 | ||
| Low | 36.15 on 06/28/23 | 45.89 on 07/28/26 | 24.99 on 07/27/26 | ||
| High | 39.99 on 07/10/23 | 62.53 on 08/21/26 | 30.96 on 08/19/26 | ||
| 3-Month | |||||
| %Chg | +46.66% since 04/10/23 | +20.93% since 05/22/26 | +44.88% since 05/22/26 | ||
| Low | 27.23 on 04/11/23 | 45.89 on 07/28/26 | 20.75 on 06/02/26 | ||
| High | 39.99 on 07/10/23 | 63.45 on 07/06/26 | 30.96 on 08/19/26 | ||
| 6-Month | |||||
| %Chg | +113.98% since 01/10/23 | +10.33% since 02/25/26 | +22.43% since 02/25/26 | ||
| Low | 18.25 on 01/11/23 | 44.12 on 03/30/26 | 19.89 on 03/19/26 | ||
| High | 39.99 on 07/10/23 | 63.45 on 07/06/26 | 30.96 on 08/19/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,504,431 | 5,518,753 | 5,108,873 | ||
| Shares Outstanding, K | 137,783 | 96,693 | 172,306 | ||
| Annual Sales, $M | 0 | 3,510,000 | 1,071,510,000 | ||
| Annual Net Income, $M | -185,210,000 | -581,600,000 | 391,000,000 | ||
| Last Qtr Sales, $M | 0 | 10,180,000 | 307,960,000 | ||
| Last Qtr Income, $M | -72,230,000 | -91,150,000 | 31,500,000 | ||
| 60-Month Beta | 1.07 | 1.74 | 0.81 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.53 on 05/10/23 | -0.94 on 08/03/26 | 0.18 on 08/04/26 | ||
| Latest Earnings Date | 07/25/23 | 11/09/26 | 11/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 47.58 | ||